Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerations

Area of Science:

• Vascular Biology and Regenerative Medicine
• Cellular and Molecular Medicine
• Cardiovascular Research

Background:

• Peripheral circulating cells, particularly endothelial progenitor cells (EPCs), are key to vasculogenesis and endothelial repair.
• The heterogeneity of EPCs necessitates standardized analytical approaches for reliable study.
• EPCs, identified as CD34(+)/KDR(+)/CD45(dim) cells, show promise as biomarkers in cardiovascular diseases.

Purpose of the Study:

• To review critical pre-analytical and analytical factors for quantifying CD34(+)/KDR(+)/CD45(dim) EPCs.
• To provide technical recommendations for improving the accuracy and reproducibility of EPC enumeration.
• To address the need for standardized protocols in EPC research.

Main Methods:

• Detailed description of pre-analytical variables affecting EPC quantification.
• In-depth analysis of analytical factors in flow cytometry for EPC enumeration.
• Review of established and emerging techniques for EPC identification and quantification.

Main Results:

• Identification of key pre-analytical factors influencing EPC counts.
• Elucidation of critical analytical parameters for accurate flow cytometry.
• Recommendations for optimizing assay conditions to enhance reproducibility.

Conclusions:

• Standardized protocols are essential for reliable quantification of EPCs.
• Accurate enumeration of CD34(+)/KDR(+)/CD45(dim) EPCs is vital for their use as cardiovascular biomarkers.
• Adherence to best practices in flow cytometry will advance vascular research.